Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab (Q38419887)
Jump to navigation
Jump to search
scientific article published on 14 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab |
scientific article published on 14 October 2014 |
Statements
1 reference
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab (English)
1 reference
Conrad Chan
Karen Lam
14 October 2014
1 reference